ACTU
ACTU
NASDAQ · Biotechnology

Actuate Therapeutics Inc

$4.41
+0.09 (+2.08%)
As of Feb 8, 2:11 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +412.9% upside
Low Target $15.82
Average Target $22.62
High Target $24.89
Current Price $4.41
Current
$4.41
Target
$22.62
$15.82 $22.62 avg $24.89
Scenario Analysis
Bear Case
$15.82
258.7%
Low target
Base Case
$22.62
+412.9%
Avg target
Bull Case
$24.89
+464.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$24.77
-82.2% from high
52-Week Low
$14.44
+-69.5% from low
Target vs 52W High
$22.62
-8.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%